Erminio Costa

Erminio Costa (1924, Cagliari, Italy - 2009, Washington, D.C., USA) was a neuroscientist.[1] His research interests covered brain serotonergic activity in health and disease, benzodiazepine-GABA interactions,[2] benzodiazepine action at GABAA receptors, and GABAergic dysfunction and changes in the expression of reelin and GAD67 in schizophrenia.[3] He published more than 1000 articles.[4]

Contents

Career

Books

See also

References

  1. ^ Clayton, Paula J.; Fatemi, S. Hossein (2008). The medical basis of psychiatry. Totowa, NJ: Humana Press. ISBN 1-58829-917-1. 
  2. ^ Barondes, Samuel H. (2003). Better than Prozac: Creating the next generation of psychiatric drugs. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-515130-5. 
  3. ^ Costa E, Chen Y, Davis J, Dong E, Noh JS, Tremolizzo L, Veldic M, Grayson DR, Guidotti A (February 2002). "REELIN and schizophrenia: a disease at the interface of the genome and the epigenome". Mol. Interv. 2 (1): 47–57. doi:10.1124/mi.2.1.47. PMID 14993361. http://molinterv.aspetjournals.org/cgi/pmidlookup?view=long&pmid=14993361. 
  4. ^ "UIC, Dept. of Psychiatry News: Erminio Costa, M.D., Logs 1,000th Publication". http://www.psych.uic.edu/news/costa.htm. 

External links